The rise of generative AI and other automation technologies will surely create efficiencies within the $4.5 trillion healthcare industry. But for early stage startups taking a swing at digital health,… Read More
One of Seattle’s biggest and longest active venture capital firms is looking to jump into the SPAC arena. Frazier Healthcare Partners — which has invested in biotechnology companies since 1991… Read More
The U.S. healthcare system faces a myriad of challenges today, including uncertainty over federal regulation and shifting payer systems. You might expect that environment to give pause to many investors.… Read More
Frazier Healthcare has raised $262 million for its latest life sciences venture fund that will back early stage therapeutics companies, according to an SEC document filed on Thursday. The Seattle-based… Read More
—Cyanogen, the makers of modified versions of Android for mobile devices, has snagged two executives from Amazon and Qualcomm to expand international operations. Former Amazon Vice President of Traffic Stephen Lawler is… Read More
Frazier Healthcare has raised a $377 million fund, one of the largest in recent years by a Seattle venture firm. The firm, whose portfolio includes Achaogen, Atterocor, Portola Pharmaceuticals and other… Read More
Frazier Healthcare, a 21-year-old venture capital firm with offices in Seattle and Silicon Valley, has filed documents with the Securities and Exchange Commission to raise up to $400 million for… Read More
